Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
10.03.26
/
50%
€429.85
Target price
10.03.27
€512.68
Performance (%)
-9.79%
Price
05.06.26
€387.75
Summary
This prediction is currently active. With a performance of -9.79%, the BUY prediction for Vertex Pharmaceuticals Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 10.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.082% | 1.082% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) had its price target raised by Morgan Stanley from $570.00 to $596.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.25
05.05.26
05.05.26
€527.05
05.05.27
05.05.27
8.54%
05.06.26
05.06.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
4.36%
05.06.26
05.06.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€420.00
13.02.26
13.02.26
-
13.02.27
13.02.27
-7.68%
05.06.26
05.06.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
3.15%
05.06.26
05.06.26